Clinical trial
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients…
NCT00004931 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004931 |
|---|---|
| Title | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer |
| Official title | A Clinical Trial Comparing 5-Fluorouracil (5-FU) Plus Leucovorin (LV) and Oxaliplatin With 5-FU Plus LV for the Treatment of Patients With Stages II and III Carcinoma of the Colon |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stage II Colon Cancer, Stage III Colon Cancer |
| Intervention type | Drug, Other |
| Interventions | leucovorin calcium, fluorouracil, oxaliplatin, laboratory biomarker analysis |
| Enrollment | 2,472 |
| Start date | Feb 1, 2000 |
| Primary completion | Sep 1, 2005 |
| First posted | May 14, 2003 |
| Last update posted | Jan 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: